Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study

被引:44
|
作者
Steinberg, Martin [1 ]
Hess, Kyle [2 ]
Corcoran, Chris [2 ,3 ]
Mielke, Michelle M. [4 ]
Norton, Maria [2 ,5 ,6 ]
Breitner, John [7 ,8 ]
Green, Robert [9 ,10 ]
Leoutsakos, Jeannie [1 ]
Welsh-Bohmer, Kathleen [11 ]
Lyketsos, Constantine [1 ]
Tschanz, Joann [2 ,5 ]
机构
[1] Johns Hopkins Bayview Med Ctr, Dept Psychiat & Behav Sci, Baltimore, MD 21224 USA
[2] Utah State Univ, Ctr Epidemiol Studies, Logan, UT 84322 USA
[3] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA
[4] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA
[5] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA
[6] Utah State Univ, Dept Psychol, Logan, UT 84322 USA
[7] McGill Univ, Fac Med, Ctr Studies Prevent Alzheimers Dis, Douglas Mental Hlth Inst Res Ctr, Montreal, PQ, Canada
[8] McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ H3A 2T5, Canada
[9] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA
[10] Harvard Univ, Sch Med, Boston, MA USA
[11] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA
关键词
dementia; Alzheimer's disease; neuropsychiatric; vascular; MINI-MENTAL-STATE; QUALITY-OF-LIFE; PSYCHOLOGICAL SYMPTOMS; ANTIPSYCHOTIC-DRUGS; DEMENTIA BPSD; DEPRESSION; PREVALENCE; ASSOCIATION; SERTRALINE; DELUSIONS;
D O I
10.1002/gps.3980
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
ObjectiveKnowledge of potentially modifiable risk factors for neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) is important. This study longitudinally explores modifiable vascular risk factors for NPS in AD. MethodsParticipants enrolled in the Cache County Study on Memory in Aging with no dementia at baseline were subsequently assessed over three additional waves, and those with incident (new onset) dementia were invited to join the Dementia Progression Study for longitudinal follow-up. A total of 327 participants with incident AD were identified and assessed for the following vascular factors: atrial fibrillation, hypertension, diabetes mellitus, angina, coronary artery bypass surgery, myocardial infarction, cerebrovascular accident, and use of antihypertensive or diabetes medicines. A vascular index (VI) was also calculated. NPS were assessed over time using the Neuropsychiatric Inventory (NPI). Affective and Psychotic symptom clusters were assessed separately. The association between vascular factors and change in NPI total score was analyzed using linear mixed model and in symptom clusters using a random effects model. ResultsNo individual vascular risk factors or the VI significantly predicted change in any individual NPS. The use of antihypertensive medications more than four times per week was associated with higher total NPI and Affective cluster scores. ConclusionsUse of antihypertensive medication was associated with higher total NPI and Affective cluster scores. The results of this study do not otherwise support vascular risk factors as modifiers of longitudinal change in NPS in AD. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 50 条
  • [41] Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study
    Clark, Emily
    Perin, Jamie
    Herrmann, Nathan
    Brawman-Mintzer, Olga
    Lanctot, Krista L.
    Lerner, Alan J.
    Mintzer, Jacobo
    Padala, Prasad R.
    Rosenberg, Paul B.
    Sami, Susie
    Shade, David M.
    van Dyck, Christopher H.
    Porsteinsson, Anton P.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2023, 9 (03)
  • [42] Anatomical Correlates of the Neuropsychiatric Symptoms in Alzheimer's Disease
    Hu, Xiaochen
    Meiberth, Dix
    Newport, Beate
    Jessen, Frank
    CURRENT ALZHEIMER RESEARCH, 2015, 12 (03) : 266 - 277
  • [43] Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
    Geda, Yonas E.
    Schneider, Lon S.
    Gitlin, Laura N.
    Miller, David S.
    Smith, Gwenn S.
    Bell, Joanne
    Evans, Jovier
    Lee, Michael
    Porsteinsson, Anton
    Lanctot, Krista L.
    Rosenberg, Paul B.
    Sultzer, David L.
    Francis, Paul T.
    Brodaty, Henry
    Padala, Prasad P.
    Onyike, Chiadikaobi U.
    Ortiz, Luis Agueera
    Ancoli-Israel, Sonia
    Bliwise, Donald L.
    Martin, Jennifer L.
    Vitiello, Michael V.
    Yaffe, Kristine
    Zee, Phyllis C.
    Herrmann, Nathan
    Sweet, Robert A.
    Ballard, Clive
    Khin, Ni A.
    Alfaro, Cara
    Murray, Patrick S.
    Schultz, Susan
    Lyketsos, Constantine G.
    ALZHEIMERS & DEMENTIA, 2013, 9 (05) : 602 - 608
  • [44] Vascular Risk Factors and Alzheimer's Disease
    Urbanova, B.
    Tomek, A.
    Mikulik, R.
    Magerova, H.
    Sheardova, K.
    Horinek, D.
    Hort, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2012, 75 (06) : 694 - 699
  • [45] Vascular risk factors and Alzheimer's disease
    O'Brien, John T.
    Markus, Hugh S.
    BMC MEDICINE, 2014, 12
  • [46] Relationship of Neuropsychiatric Symptoms with Falls in Alzheimer's Disease - Does Exercise Modify the Risk?
    Roitto, Hanna-Maria
    Kautiainen, Hannu
    Ohman, Hannareeta
    Savikko, Niina
    Strandberg, Timo E.
    Raivio, Minna
    Laakkonen, Marja-Liisa
    Pitkala, Kaisu H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (12) : 2377 - 2381
  • [47] Sex differences in the severity of neuropsychiatric symptoms and their relationship with clinico-demographic and psychosocial factors in patients with amnestic mild cognitive impairment and mild Alzheimer's disease
    Inamura, Keisuke
    Shinagawa, Shunichiro
    Tsuneizumi, Yuri
    Nagata, Tomoyuki
    Tagai, Kenji
    Nukariya, Kazutaka
    Shigeta, Masahiro
    AGING & MENTAL HEALTH, 2020, 24 (03) : 431 - 438
  • [48] Vascular risk factors and Alzheimer’s disease
    John T O’Brien
    Hugh S Markus
    BMC Medicine, 12
  • [49] Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study
    Nagata, Tomoyuki
    Nakajima, Shinichiro
    Shinagawa, Shunichiro
    Plitman, Eric
    Graff-Guerrero, Ariel
    Mimura, Masaru
    Nakayama, Kazuhiko
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32 (12) : 1264 - 1271
  • [50] Can impairment in memory, language and executive functions predict neuropsychiatric symptoms in Alzheimer's disease (AD)? Findings from a cross-sectional study
    Maria Garcia-Alberca, Jose
    Pablo Lara, Jose
    Luis Berthier, Marcelo
    Cruz, Belen
    Angel Barbancho, Miguel
    Green, Cristina
    Gonzalez-Baron, Salvador
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2011, 52 (03) : 264 - 269